Andere Sprachen FibroGen, Inc.

Aktien

A12EZ0

US31572Q8087

FGEN

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 15.04.2024			% 5 Tage	% 1. Jan.
1.31 ^USD	+0.77%		-19.63%	+47.81%

15.04.	Faron Pharmaceuticals beruft ehemaligen Finanzchef auf Interimsbasis wieder ein	AN
03.04.	Top-Mittagskursrückgänge	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Faron Pharmaceuticals reappoints former finance chief on interim basis	15.04.
Top Midday Decliners	03.04.
FibroGen Says Phase 1 Study of Potential Prostate Cancer Treatment Shows Promise	03.04.
FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer	02.04.
Fibrogen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer	02.04.
FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference	26.03.
FibroGen : Corporate Presentation – March 2024	19.03.
Sector Update: Health Care Stocks Rise Late Afternoon	12.03.
Sector Update: Health Care Stocks Higher in Afternoon Trading	12.03.
FibroGen Shares Jump After CEO Stock Purchase	12.03.
FibroGen Names Deyaa Adib Chief Medical Officer	11.03.
FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer	11.03.
FibroGen Appoints Deyaa Adib as Senior Vice President and Chief Medical Officer	11.03.
FibroGen : Corporate Presentation – March 2024	06.03.
FibroGen: Q4 Earnings Snapshot	26.02.
FibroGen regains rights to anemia drug from AstraZeneca	26.02.
FibroGen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26.02.
Earnings Flash (FGEN) FIBROGEN Reports Q4 Revenue $27.1M, vs. Street Est of $38.8M	26.02.
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results	26.02.
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZeneca Territories, Except China and South Korea	26.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen FibroGen, Inc.

Aktien

A12EZ0

US31572Q8087

FGEN

Andere Sprachen

Filter